337 related articles for article (PubMed ID: 28389141)
1. Luteolin restricts dengue virus replication through inhibition of the proprotein convertase furin.
Peng M; Watanabe S; Chan KWK; He Q; Zhao Y; Zhang Z; Lai X; Luo D; Vasudevan SG; Li G
Antiviral Res; 2017 Jul; 143():176-185. PubMed ID: 28389141
[TBL] [Abstract][Full Text] [Related]
2. Luteolin escape mutants of dengue virus map to prM and NS2B and reveal viral plasticity during maturation.
Peng M; Swarbrick CMD; Chan KW; Luo D; Zhang W; Lai X; Li G; Vasudevan SG
Antiviral Res; 2018 Jun; 154():87-96. PubMed ID: 29665375
[TBL] [Abstract][Full Text] [Related]
3. Nordihydroguaiaretic acid (NDGA) inhibits replication and viral morphogenesis of dengue virus.
Soto-Acosta R; Bautista-Carbajal P; Syed GH; Siddiqui A; Del Angel RM
Antiviral Res; 2014 Sep; 109():132-40. PubMed ID: 25017471
[TBL] [Abstract][Full Text] [Related]
4. Narasin, a novel antiviral compound that blocks dengue virus protein expression.
Low JS; Wu KX; Chen KC; Ng MM; Chu JJ
Antivir Ther; 2011; 16(8):1203-18. PubMed ID: 22155902
[TBL] [Abstract][Full Text] [Related]
5. Human Subtilisin Kexin Isozyme-1 (SKI-1)/Site-1 Protease (S1P) regulates cytoplasmic lipid droplet abundance: A potential target for indirect-acting anti-dengue virus agents.
Hyrina A; Meng F; McArthur SJ; Eivemark S; Nabi IR; Jean F
PLoS One; 2017; 12(3):e0174483. PubMed ID: 28339489
[TBL] [Abstract][Full Text] [Related]
6. Targeting heat shock factor 1 as an antiviral strategy against dengue virus replication in vitro and in vivo.
Tsai TT; Chen CL; Tsai CC; Lin CF
Antiviral Res; 2017 Sep; 145():44-53. PubMed ID: 28733114
[TBL] [Abstract][Full Text] [Related]
7. Suppressive Effects of the Site 1 Protease (S1P) Inhibitor, PF-429242, on Dengue Virus Propagation.
Uchida L; Urata S; Ulanday GE; Takamatsu Y; Yasuda J; Morita K; Hayasaka D
Viruses; 2016 Feb; 8(2):. PubMed ID: 26875984
[TBL] [Abstract][Full Text] [Related]
8. Dengue Virus Evolution under a Host-Targeted Antiviral.
Plummer E; Buck MD; Sanchez M; Greenbaum JA; Turner J; Grewal R; Klose B; Sampath A; Warfield KL; Peters B; Ramstedt U; Shresta S
J Virol; 2015 May; 89(10):5592-601. PubMed ID: 25762732
[TBL] [Abstract][Full Text] [Related]
9. A novel inhibitor of dengue virus replication that targets the capsid protein.
Byrd CM; Dai D; Grosenbach DW; Berhanu A; Jones KF; Cardwell KB; Schneider C; Wineinger KA; Page JM; Harver C; Stavale E; Tyavanagimatt S; Stone MA; Bartenschlager R; Scaturro P; Hruby DE; Jordan R
Antimicrob Agents Chemother; 2013 Jan; 57(1):15-25. PubMed ID: 23070172
[TBL] [Abstract][Full Text] [Related]
10. Enhancing dengue virus maturation using a stable furin over-expressing cell line.
Mukherjee S; Sirohi D; Dowd KA; Chen Z; Diamond MS; Kuhn RJ; Pierson TC
Virology; 2016 Oct; 497():33-40. PubMed ID: 27420797
[TBL] [Abstract][Full Text] [Related]
11. The kinase inhibitor SFV785 dislocates dengue virus envelope protein from the replication complex and blocks virus assembly.
Anwar A; Hosoya T; Leong KM; Onogi H; Okuno Y; Hiramatsu T; Koyama H; Suzuki M; Hagiwara M; Garcia-Blanco MA
PLoS One; 2011; 6(8):e23246. PubMed ID: 21858043
[TBL] [Abstract][Full Text] [Related]
12. Schisandrin A inhibits dengue viral replication via upregulating antiviral interferon responses through STAT signaling pathway.
Yu JS; Wu YH; Tseng CK; Lin CK; Hsu YC; Chen YH; Lee JC
Sci Rep; 2017 Mar; 7():45171. PubMed ID: 28338050
[TBL] [Abstract][Full Text] [Related]
13. AR-12 suppresses dengue virus replication by down-regulation of PI3K/AKT and GRP78.
Chen HH; Chen CC; Lin YS; Chang PC; Lu ZY; Lin CF; Chen CL; Chang CP
Antiviral Res; 2017 Jun; 142():158-168. PubMed ID: 28238876
[TBL] [Abstract][Full Text] [Related]
14. Decanoyl-Arg-Val-Lys-Arg-Chloromethylketone: An Antiviral Compound That Acts against Flaviviruses through the Inhibition of Furin-Mediated prM Cleavage.
Imran M; Saleemi MK; Chen Z; Wang X; Zhou D; Li Y; Zhao Z; Zheng B; Li Q; Cao S; Ye J
Viruses; 2019 Oct; 11(11):. PubMed ID: 31683742
[TBL] [Abstract][Full Text] [Related]
15. Anti-inflammatory Compound Shows Therapeutic Safety and Efficacy against Flavivirus Infection.
Chuang FK; Huang SM; Liao CL; Lee AR; Lien SP; Chiu YL; Chang TH; Tsai PL; Lin RJ; Shih CC; Tsai YJ; Lin GJ; Yen LC
Antimicrob Agents Chemother; 2019 Dec; 64(1):. PubMed ID: 31636070
[TBL] [Abstract][Full Text] [Related]
16. Alterations of pr-M cleavage and virus export in pr-M junction chimeric dengue viruses.
Keelapang P; Sriburi R; Supasa S; Panyadee N; Songjaeng A; Jairungsri A; Puttikhunt C; Kasinrerk W; Malasit P; Sittisombut N
J Virol; 2004 Mar; 78(5):2367-81. PubMed ID: 14963133
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of dengue virus replication by novel inhibitors of RNA-dependent RNA polymerase and protease activities.
Pelliccia S; Wu YH; Coluccia A; La Regina G; Tseng CK; Famiglini V; Masci D; Hiscott J; Lee JC; Silvestri R
J Enzyme Inhib Med Chem; 2017 Dec; 32(1):1091-1101. PubMed ID: 28776445
[TBL] [Abstract][Full Text] [Related]
18. Dengue Virus Targets Nrf2 for NS2B3-Mediated Degradation Leading to Enhanced Oxidative Stress and Viral Replication.
Ferrari M; Zevini A; Palermo E; Muscolini M; Alexandridi M; Etna MP; Coccia EM; Fernandez-Sesma A; Coyne C; Zhang DD; Marques ETA; Olagnier D; Hiscott J
J Virol; 2020 Nov; 94(24):. PubMed ID: 32999020
[TBL] [Abstract][Full Text] [Related]
19. Functional importance of dengue virus maturation: infectious properties of immature virions.
Zybert IA; van der Ende-Metselaar H; Wilschut J; Smit JM
J Gen Virol; 2008 Dec; 89(Pt 12):3047-3051. PubMed ID: 19008392
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of dengue virus by an ester prodrug of an adenosine analog.
Chen YL; Yin Z; Lakshminarayana SB; Qing M; Schul W; Duraiswamy J; Kondreddi RR; Goh A; Xu HY; Yip A; Liu B; Weaver M; Dartois V; Keller TH; Shi PY
Antimicrob Agents Chemother; 2010 Aug; 54(8):3255-61. PubMed ID: 20516277
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
